Sweden
· Delayed Price · Currency is SEK Vitrolife AB Statistics
Total Valuation
Vitrolife AB has a market cap or net worth of SEK 33.44 billion. The enterprise value is 34.69 billion.
| Market Cap | 33.44B |
| Enterprise Value | 34.69B |
Important Dates
The next estimated earnings date is Thursday, October 24, 2024.
| Earnings Date | Oct 24, 2024 |
| Ex-Dividend Date | Apr 26, 2024 |
Share Statistics
Vitrolife AB has 135.39 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Shares Outstanding | 135.39M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 0.07% |
| Owned by Institutions (%) | 75.71% |
| Float | 74.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 44.83 |
| PS Ratio | 9.46 |
| PB Ratio | 2.55 |
| P/FCF Ratio | 46.26 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.40, with an EV/FCF ratio of 47.98.
| EV / Earnings | -9.13 |
| EV / Sales | 9.81 |
| EV / EBITDA | 29.40 |
| EV / EBIT | 44.64 |
| EV / FCF | 47.98 |
Financial Position
The company has a current ratio of 2.99, with a Debt / Equity ratio of 16.00.
| Current Ratio | 2.99 |
| Quick Ratio | 2.32 |
| Debt / Equity | 16.00 |
| Debt / EBITDA | 1.78 |
| Debt / FCF | 2.90 |
| Interest Coverage | 8.27 |
Financial Efficiency
Return on equity (ROE) is -24.68% and return on invested capital (ROIC) is 2.76%.
| Return on Equity (ROE) | -24.68% |
| Return on Assets (ROA) | 2.52% |
| Return on Capital (ROIC) | 2.76% |
| Revenue Per Employee | 3.17M |
| Profits Per Employee | -3.41M |
| Employee Count | 1,115 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 3.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +68.03% in the last 52 weeks. The beta is 1.77, so Vitrolife AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.77 |
| 52-Week Price Change | +68.03% |
| 50-Day Moving Average | 206.86 |
| 200-Day Moving Average | 188.76 |
| Relative Strength Index (RSI) | 73.10 |
| Average Volume (20 Days) | 79,868 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitrolife AB had revenue of SEK 3.54 billion and -3.80 billion in losses. Loss per share was -28.06.
| Revenue | 3.54B |
| Gross Profit | 2.03B |
| Operating Income | 777.00M |
| Pretax Income | -3.64B |
| Net Income | -3.80B |
| EBITDA | 1.15B |
| EBIT | 777.00M |
| Loss Per Share | -28.06 |
Balance Sheet
The company has 853.00 million in cash and 2.10 billion in debt, giving a net cash position of -1.24 billion or -9.17 per share.
| Cash & Cash Equivalents | 853.00M |
| Total Debt | 2.10B |
| Net Cash | -1.24B |
| Net Cash Per Share | -9.17 |
| Equity (Book Value) | 13.10B |
| Book Value Per Share | 96.71 |
| Working Capital | 1.33B |
Cash Flow
In the last 12 months, operating cash flow was 819.00 million and capital expenditures -96.00 million, giving a free cash flow of 723.00 million.
| Operating Cash Flow | 819.00M |
| Capital Expenditures | -96.00M |
| Free Cash Flow | 723.00M |
| FCF Per Share | 5.34 |
Margins
Gross margin is 57.48%, with operating and profit margins of 21.98% and -107.47%.
| Gross Margin | 57.48% |
| Operating Margin | 21.98% |
| Pretax Margin | -103.03% |
| Profit Margin | -107.47% |
| EBITDA Margin | 32.48% |
| EBIT Margin | 21.98% |
| FCF Margin | 20.45% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.45%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.45% |
| Dividend Growth (YoY) | 17.65% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.00% |
| Shareholder Yield | 0.44% |
| Earnings Yield | -11.36% |
| FCF Yield | 2.16% |
Stock Splits
The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.
| Last Split Date | May 17, 2018 |
| Split Type | Forward |
| Split Ratio | 5 |